Clinical and microbial characteristics of invasive Streptococcus pyogenes disease in New Caledonia, a region in oceania with a high incidence of acute rheumatic fever

Journal of Clinical Microbiology

Volumn 48, Issue 2, 2010, Pages 526-530

  Le Hello, S ^a   Doloy, A ^b   Baumann, F ^a   Roques, N ^c   Coudene, P ^a   Rouchon, B ^d   Lacassin, F ^c   Bouvet, A ^b  

^a Institut Pasteur de Nouvelle Caledonie Noumea   (New Caledonia)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c CHT Magenta   (New Caledonia)

^d Department and Agency of Health and Social Affairs of New Caledonia ^*  (New Caledonia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; STREPTOCOCCUS VACCINE;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL ARTHRITIS; BACTERIAL GENE; BACTERIAL STRAIN; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; EMM106 STRAIN; EMM109 STRAIN; EMM15 STRAIN; EMM74 STRAIN; EMM89 STRAIN; EMM92 STRAIN; ENDOCARDITIS; ERYSIPELAS; FEMALE; GROUP A STREPTOCOCCAL INFECTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MYOSITIS; NECROTIZING FASCIITIS; NEW CALEDONIA; NONHUMAN; OBESITY; OSTEOMYELITIS; PACIFIC ISLANDS; PRIORITY JOURNAL; PUERPERAL INFECTION; RHEUMATIC FEVER; SKIN DEFECT; SPEA GENE; SPEB GENE; SPEC GENE; STREPTOCOCCUS PYOGENES;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; FEMALE; GENOTYPE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NEW CALEDONIA; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; VIRULENCE FACTORS; YOUNG ADULT;

SPEA; STREPTOCOCCUS PYOGENES;

EID: 75649112611     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01205-09     Document Type: Article

References (24)

1. Aziz, R. K., and M. Kotb. 2008. Rise and persistence of global M1T1 clone of Streptococcus pyogenes. Emerg. Infect. Dis. 14:1511-1517.
2. Beall, B., R. Facklam, and T. Thompson. 1996. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J. Clin. Microbiol. 34:953-958.
3. Berkley, J. A., B. S. Lowe, I. Mwangi, T. Williams, E. Bauni, S. Mwarumba, C. Ngetsa, M. P. Slack, S. Njenga, C. A. Hart, K. Maitland, M. English, K. Marsh, and J. A. Scott. 2005. Bacteremia among children admitted to a rural hospital in Kenya. N. Engl. J. Med. 352:39-47.
4. Bessen, D. E., J. R. Carapetis, B. Beall, R. Katz, M. Hibble, B. J. Currie, T. Collingridge, M. W. Izzo, D. A. Scaramuzzino, and K. S. Sriprakash. 2000. Contrasting molecular epidemiology of group A streptococci causing tropical and nontropical infections of the skin and throat. J. Infect. Dis. 182:1109-1116.
5. Bouvet, A., P. Geslin, P. Kriz-Kuzemenska, V. Blanc, C. Devine, and F. Grimont. 1994. Restricted association between biotypes and serotypes within group A streptococci. J. Clin. Microbiol. 32:1312-1317.
6. Carapetis, J. R., A. C. Steer, E. K. Mulholland, and M. Weber. 2005. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 5:685-694.
7. Centers for Disease Control and Prevention. 2006. Streptococcus pyogenes emm sequence database. http://www.cdc.gov/ncidod/biotech/strep/ emmtypes.htm.
8. Chatellier, S., N. Ihendyane, R. G. Kansal, F. Khambaty, H. Basma, A. Norrby-Teglund, D. E. Low, A. McGeer, and M. Kotb. 2000. Genetic relatedness and superantigen expression in group A streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases. Infect. Immun. 68:3523-3534.
9. Cunningham, M. W. 2000. Pathogenesis of group A streptococcal infections. Clin. Microbiol. Rev. 13:470-511.
10. Erdem, G., C. Mizumoto, D. Esaki, L. Abe, V. Reddy, and P. V. Effler. 2009. Streptococcal emm types in Hawaii: a region with high incidence of acute rheumatic fever. Pediatr. Infect. Dis. J. 28:13-16.
11. Johnson, D. R., E. L. Kaplan, J. Sramek, R. Bicova, J. Havlicek, H. Havlickova, J. Motlova, and P. Kriz. 1996. Determination of T-protein agglutination patterns, p. 37-41. In D. R. Johnson, E. L. Kaplan, J. Sramek, R. Bicova, J. Havlicek, H. Havlickova, J. Motlova, and P. Kriz (ed.), Laboratory diagnosis of group A streptococcal infections. World Health Organization, Geneva, Switzerland.
12. Johnson, D. R., D. L. Stevens, and E. L. Kaplan. 1992. Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis. J. Infect. Dis. 166:374-382.
13. Kotb, M. 1995. Bacterial pyrogenic exotoxins as superantigens. Clin. Microbiol. Rev. 8:411-426.
14. Luca-Harari, B., J. Darenberg, S. Neal, T. Siljander, L. Strakova, A. Tanna, R. Creti, K. Ekelund, M. Koliou, P. T. Tassios, M. van der Linden, M. Straut, J. Vuopio-Varkila, A. Bouvet, A. Efstratiou, C. Schalén, B. Henriques-Normark, the Strep-EURO Study Group, and A. Jasir. 2009. Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe. J. Clin. Microbiol. 47:1155-1165.
15. Martin, D. R., L. M. Voss, S. J. Walker, and D. Lennon. 1994. Acute rheumatic fever in Auckland, New Zealand: spectrum of associated group A streptococci different from expected. Pediatr. Infect. Dis. J. 13:264-269.
16. McNeil, S. A., S. A. Halperin, J. M. Langley, B. Smith, A. Warren, G. P. Sharratt, D. M. Baxendale, M. A. Reddish, M. C. Hu, S. D. Stroop, J. Linden, L. F. Fries, P. E. Vink, and J. B. Dale. 2005. Safety and immunogenicity of 26-valent group A Streptococcus vaccine in healthy adult volunteers. Clin. Infect. Dis. 41:1114-1122.
17. Norton, R., H. V. Smith, N. Wood, E. Siegbrecht, A. Ross, and N. Ketheesan. 2004. Invasive group A streptococcal disease in North Queensland (1996-2001). Indian J. Med. Res. 119(Suppl.):148-151.
18. O'Brien, K. L., B. Beall, N. L. Barrett, P. R. Cieslak, A. Reingold, M. M. Farley, R. Danila, E. R. Zell, R. Facklam, B. Schwartz, and A. Schuchat. 2002. Epidemiology of invasive group A streptococcus disease in the United States, 1995-1999. Clin. Infect. Dis. 35:268-276.
19. O'Loughlin, R. E., A. Roberson, P. R. Cieslak, R. Lynfield, K. Gershman, A. Craig, B. A. Albanese, M. M. Farley, N. L. Barrett, N. L. Spina, B. Beall, L. H. Harrison, A. Reingold, and C. Van Beneden for the Active Bacterial Core Surveillance Team. 2007. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin. Infect. Dis. 45:853-862.
20. Schwartz, B., R. R. Facklam, and R. F. Breiman. 1990. Changing epidemiology of group A streptococcal infection in the USA. Lancet 336:1167-1171.
21. Steer, A. C., N. Curtis, and J. R. Carapetis. 2007. Diagnosis and treatment of invasive group A streptococcal infections. Expert Opin. Med. Diagnostics 2:289-302.
22. Steer, A. C., A. Jenney, J. Kado, M. F. Good, M. Batzloff, L. Waqatakirewa, E. K. Mullholland, and J. R. Carapetis. 2009. Prospective surveillance of invasive group A streptococcal disease, Fiji, 2005-2007. Emerg. Infect. Dis. 15:216-222.
23. Steer, A. C., A. J. Jenney, F. Oppedisano, M. R. Batzloff, J. Hartas, J. Passmore, F. M. Russell, J. H. Kado, and J. R. Carapetis. 2008. High burden of invasive β-haemolytic streptococcal infections in Fiji. Epidemiol. Infect. 136:621-627.
24. Working Group on Severe Streptococcal Infections. 1993. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. JAMA 269:390-391.